Beckett Hart

Fueled by genuine curiosity about what’s next in biopharma, Beckett combines sharp strategic thinking with an approachable style that inspires teams and partners alike. 

Beckett joined The NemetzGroup in 2025, bringing over 15 years in consulting and biopharma industry roles. Beckett is skilled in financial modeling, new product planning, due diligence, competitive intelligence, and building strong stakeholder relationships. She currently advises senior biopharma leaders, helping clients navigate commercialization, portfolio strategy, and corporate storytelling.

Most recently, Beckett served as Senior Director and Head of Corporate Development and Strategy at Carbon Biosciences, leading business development strategy, investor relations, and cross-functional strategic planning. In this role, she broadened her understanding of the development and commercialization challenges in gene therapy. Beckett has held leadership roles in new product planning at Syros Pharmaceuticals and managed corporate development and strategy at Cyclerion and Ironwood.

She began her career as a consultant to the life sciences industry at Back Bay Life Science Advisors, Quintiles/IMS (now IQVIA), and Red Sky Partners, providing insights on asset identification, competitive analysis, and M&A benchmarking.

Beckett holds an MBA from Boston University and a BA from the University of Colorado, magna cum laude.